{"database": "lobbying", "table": "lobbying_activities", "rows": [[2461804, "d5656b5c-cf96-4665-9f86-5ef6f35db644", "Q2", "HOLLAND & KNIGHT LLP", 18466, "TEVA PHARMACEUTICALS USA, INC.", 2020, "second_quarter", "PHA", "Drug pricing; Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074); Families First Coronavirus Response Act (H.R. 6201); Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748); Global supply chain issues; National Defense Authorization Act.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-07-07T13:26:04.840000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2461804"], "units": {}, "query_ms": 18.50440609268844, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}